apixaban우선순위 중간ICSR 검토기타
LITERATURE DETAIL · PMID 42561468
Oral anticoagulants reduce venous thromboembolism rates in patients on 1st-line treatment for ovarian Cancer- A quality improvement project.
Oral anticoagulants reduce venous thromboembolism rates in patients on 1st-line treatment for ovarian Cancer- A quality improvement project.
- 저자
- Limor Helpman, Dana Josephy, Liat Toderis, Victoria Tkach, Noa Rotem, Daniel Shai
- 저널
- Gynecologic oncology
- 공개일
- 2026 Aug 06
- 연구 유형
- 기타
- DOI
- 10.1016/j.ygyno.2026.07.018
문헌 요약
Metastatic cancer patients receiving systemic chemotherapy face increased risks for venous thromboembolism (VTE). Benefit has been shown for prophylactic anticoagulants in risk-stratified populations. Ovarian cancer (OC) is commonly advanced at diagnosis and treated with chemotherapy. Despite high VTE rates among OC patients, predictors of risk in this po…
PV 검토 포인트
개별 증례 가능성과 중대성, 예상성 및 중복 여부를 우선 검토합니다.